SCHEMBL18847608

SCHEMBL18847608

c1ccc(-c2nc3ccccc3c3c2ccc2c4ccccc4n(-c4cccc(-c5ccc6cc(-c7ccc8ccccc8c7)ccc6c5)c4)c23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ HSD17B1 P14061 1/20 0.35
▸ HSD17B2 P37059 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TUBB4A P04350 1/20 0.34
▸ TUBB P07437 1/20 0.34
▸ TUBA3C P0DPH7 1/20 0.34
▸ TUBA1B P68363 1/20 0.34
▸ TUBA4A P68366 1/20 0.34
▸ TUBB4B P68371 1/20 0.34
▸ TUBB3 Q13509 1/20 0.34
▸ TUBB2A Q13885 1/20 0.34
▸ TUBB8 Q3ZCM7 1/20 0.34
▸ TUBA3E Q6PEY2 1/20 0.34
▸ TUBA1A Q71U36 1/20 0.34
▸ TUBA1C Q9BQE3 1/20 0.34
▸ TUBB6 Q9BUF5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18847719 0.95 GAA (0.35) GAAMEN1KMT2AHSD17B1HSD17B2
SCHEMBL18847729 0.94 TUBB4A (0.35) GAAMEN1KMT2AHSD17B1HSD17B2
SCHEMBL18846994 0.94 KDM4E (0.36) GAAMEN1KMT2AHSD17B1HSD17B2
SCHEMBL18846742 0.93 KDM4E (0.38) MEN1KMT2AHSD17B1HSD17B2TUBB4A
SCHEMBL24941576 0.92 KDM4E (0.37) KMT2AHSD17B1HSD17B2TUBB4ATUBB
SCHEMBL18847279 0.92 PIK3CD (0.36) MEN1KMT2AHSD17B1HSD17B2ALDH1A1
SCHEMBL18847731 0.92 KDM4E (0.41) GAAMEN1KMT2AALDH1A1LMNA
SCHEMBL18846762 0.91 GAA (0.37) GAAMEN1KMT2AHSD17B1HSD17B2
SCHEMBL18847298 0.91 GAA (0.38) GAAMEN1KMT2AALDH1A1LMNA
SCHEMBL18846733 0.91 KDM4E (0.41) GAAMEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 GAA 2601/4885MEN1 1034/4885KMT2A 579/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 GAA 2601/4885MEN1 1034/4885KMT2A 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback